(Q44511847)

3 December 2017

ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

1 reference

Joyce A Benjamins

1

1 reference

3 December 2017

Liljana Nedelkoska

series ordinal

2

1 reference

3 December 2017

Beverly Bealmear

series ordinal

3

1 reference

3 December 2017

Robert P Lisak

series ordinal

4

1 reference

3 December 2017

5 July 2013

1 reference

3 December 2017

1 reference

3 December 2017

61

1 reference

3 December 2017

8

1 reference

3 December 2017

1206-1217

1 reference

Functional glutamate transport in rodent optic nerve axons and glia.

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Corticosteroids for the treatment of infantile spasms: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamatergic signaling in the brain's white matter.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Intravenous methylprednisolone for multiple sclerosis in relapse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Cytokines reduce toxic effects of ethanol on oligodendroglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Brain effects of melanocortins.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Induction of a Common Pathway of Apoptosis by Staurosporine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humans

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Ingested (oral) alpha-MSH inhibits acute EAE

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Ingested (oral) ACTH inhibits EAE

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Oligodendrocyte killing by quinolinic acid in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Targeting melanocortin receptors as a novel strategy to control inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The melanocortin system in control of inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Validation of the rat model of cryptogenic infantile spasms.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Same players, different game: AMPA receptor regulation in oligodendrocyte progenitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Stress and the brain: from adaptation to disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Brain corticosteroid receptor balance in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Effective use of a neurotrophic ACTH4-9 analogue in the treatment of a peripheral demyelinating syndrome (experimental allergic neuritis). An intervention study.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Redistribution and internalization of antibodies to galactocerebroside by oligodendroglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Solubilisation partial characterisation of the alpha-MSH receptor on primary rat Schwann cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Melanocortin analogue Org2766 binds to rat Schwann cells, upregulates NGF low-affinity receptor p75, and releases neurotrophic activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Alpha-MSH rescues neurons from excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamate and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Melanocortins and the treatment of nervous system disease. Potential relevance to the skin?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Cerebral white matter contains PDGF-responsive precursors to O2A cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Characterization of specific binding sites for [3H]-staurosporine on various protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine-mediated death.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamate and ATP signalling in white matter pathology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Excitotoxic damage to white matter.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Distribution and function of melanocortin receptors within the brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The current evaluation and treatment of infantile spasms among members of the Child Neurology Society

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamate receptor expression in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

https://api.crossref.org/works/10.1002%2FGLIA.22504

1 reference

7 January 2021

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Treatment of infantile spasms: emerging insights from clinical and basic science perspectives

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Alpha-MSH inhibits inflammatory signalling in Schwann cells.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

The developing oligodendrocyte: key cellular target in brain injury in the premature infant

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Postnatal expression of melanocortin-3 receptor in rat diencephalon and mesencephalon.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Expression of melanocortin 1 receptor in periaqueductal gray matter

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Non-N-methyl-D-aspartate glutamate receptors mediate oxygen--glucose deprivation-induced oligodendroglial injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22504

7 January 2021

Identifiers

DOI

10.1002/GLIA.22504

1 reference

3 December 2017

1 reference